NeoGenomics NEO Business Segments
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| NET REVENUE by Product | |||||
| Client direct billing | $518.84M+9.1% | $475.44M+10.9% | $428.9M+15.7% | $370.71M+46.7% | |
| Commercial insurance | $117.51M+17.7% | $99.84M+13.4% | $88.02M+20.1% | $73.28M-7.0% | |
| Medicare and other government | $90.87M+7.4% | $84.6M+13.8% | $74.37M+13.4% | $65.59M-8.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does NeoGenomics break its business down?
- NeoGenomics (NEO) reports net revenue by product across 4 parts — Client direct billing, Commercial insurance, Medicare and other government and Self-pay. Each is extracted from the segment footnotes and tracked over time.
- Where does NeoGenomics's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in NeoGenomics's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
